isoxazoles has been researched along with Adverse Drug Event in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.26) | 18.2507 |
| 2000's | 7 (36.84) | 29.6817 |
| 2010's | 10 (52.63) | 24.3611 |
| 2020's | 1 (5.26) | 2.80 |
| Authors | Studies |
|---|---|
| Becker, P; Keddy, KH; Lancaster, J; Shean, K; van der Walt, ML | 1 |
| Becskei, C; Cuppens, O; Mahabir, SP | 1 |
| Beulah, TE; Maheswari, E; Singh, H; Subeesh, V; Swaroop, AM | 1 |
| Gupta, A; Gupta, PK; Sardana, K | 1 |
| Rumschlag, AJ; Ryan, WG; Snyder, DE; Young, LM | 1 |
| Supuran, CT | 1 |
| Carithers, D; Crawford, J; de Vos, C; Fourie, J; Lotriet, A | 1 |
| Cohen, L; Kessas, M; Lee, AW; Malkiewicz, IM; Neuman, MG; Shear, NH | 1 |
| Boothe, DM; Perkins, J | 1 |
| Anderson, D; Ceesay, P; Lines, C; Roth, T; Snavely, D; Vandormael, K | 1 |
| Adelsberger, JW; Ciccone, EJ; DeGrezia, M; DerSimonian, R; Higgins, J; Read, SW; Rehm, C; Sereti, I; Starling, JM | 1 |
| Bambery, P; Jose, V; Mittal, N; Mittal, R; Sharma, A; Wanchu, A | 1 |
| Cincotta, M; Tramacere, L; Zaccara, G | 1 |
| Holden, WL; Scarazzini, LJ | 1 |
| Canas, F; Eerdekens, M; Ford, L; Gassmann-Mayer, C; Kane, J; Kramer, M; Lim, P | 1 |
| Davidson, M; Eerdekens, M; Emsley, R; Ford, L; Kramer, M; Lim, P; Pan, G | 1 |
| Eerdekens, M; Ford, L; Gassmann-Mayer, C; Kramer, M; Lim, P; Samokhvalov, V; Tzimos, A | 1 |
| Davis, WM; Waters, IW | 1 |
2 review(s) available for isoxazoles and Adverse Drug Event
| Article | Year |
|---|---|
Drug interaction considerations in the therapeutic use of carbonic anhydrase inhibitors.
Topics: Acetazolamide; Anti-Inflammatory Agents, Non-Steroidal; Anti-Obesity Agents; Antibodies, Monoclonal; Anticonvulsants; Antineoplastic Agents; Benzodiazepines; Carbonic Anhydrase Inhibitors; Celecoxib; Clinical Trials as Topic; Contraindications; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Fructose; Humans; Isoxazoles; Methazolamide; Phenobarbital; Sulfanilamide; Sulfanilamides; Sulfonamides; Sulfonic Acids; Thiazines; Thiophenes; Topiramate; Zonisamide | 2016 |
Drug safety evaluation of zonisamide for the treatment of epilepsy.
Topics: Animals; Drug-Related Side Effects and Adverse Reactions; Epilepsy; Humans; Isoxazoles; Kidney Calculi; Mental Disorders; Randomized Controlled Trials as Topic; Zonisamide | 2011 |
7 trial(s) available for isoxazoles and Adverse Drug Event
| Article | Year |
|---|---|
Efficacy and safety of sarolaner in the treatment of canine ear mite infestation caused by Otodectes cynotis: a non-inferiority study.
Topics: Administration, Oral; Administration, Topical; Animals; Azetidines; Dog Diseases; Dogs; Drug-Related Side Effects and Adverse Reactions; Female; Insecticides; Isoxazoles; Macrolides; Male; Mite Infestations; Pets; Psoroptidae; Spiro Compounds | 2018 |
Speed of flea knockdown of spinosad compared to afoxolaner, and of spinosad through 28 days post-treatment in controlled laboratory studies.
Topics: Animals; Dog Diseases; Dogs; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Flea Infestations; Insecticides; Isoxazoles; Macrolides; Naphthalenes; Siphonaptera; Time Factors; United States | 2015 |
Effect of gaboxadol on patient-reported measures of sleep and waking function in patients with Primary Insomnia: results from two randomized, controlled, 3-month studies.
Topics: Adolescent; Adult; Aged; Dose-Response Relationship, Drug; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Female; GABA Agonists; Humans; Isoxazoles; Longitudinal Studies; Male; Middle Aged; Sex Characteristics; Sleep Initiation and Maintenance Disorders | 2010 |
The effect of leflunomide on cycling and activation of T-cells in HIV-1-infected participants.
Topics: Adult; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Drug-Related Side Effects and Adverse Reactions; Female; HIV Infections; HIV-1; Humans; Immunologic Factors; Isoxazoles; Leflunomide; Lymphocyte Count; Male; Phenotype; RNA, Viral; T-Lymphocytes | 2010 |
Treatment of schizophrenia with paliperidone extended-release tablets: a 6-week placebo-controlled trial.
Topics: Adult; Antipsychotic Agents; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug-Related Side Effects and Adverse Reactions; Dyskinesia, Drug-Induced; Female; Humans; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Patient Dropouts; Psychiatric Status Rating Scales; Pyrimidines; Randomized Controlled Trials as Topic; Schizophrenia; Schizophrenic Psychology; Sleep Initiation and Maintenance Disorders; Tachycardia; Treatment Outcome | 2007 |
Efficacy, safety and early response of paliperidone extended-release tablets (paliperidone ER): results of a 6-week, randomized, placebo-controlled study.
Topics: Administration, Oral; Adult; Antipsychotic Agents; Blood Glucose; Body Weight; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug-Related Side Effects and Adverse Reactions; Dyskinesia, Drug-Induced; Female; Humans; Isoxazoles; Lipids; Male; Middle Aged; Neurologic Examination; Paliperidone Palmitate; Psychiatric Status Rating Scales; Pyrimidines; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2007 |
Safety and tolerability of oral paliperidone extended-release tablets in elderly patients with schizophrenia: a double-blind, placebo-controlled study with six-month open-label extension.
Topics: Administration, Oral; Aged; Antipsychotic Agents; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Isoxazoles; Male; Paliperidone Palmitate; Prospective Studies; Pyrimidines; Schizophrenia | 2008 |
10 other study(ies) available for isoxazoles and Adverse Drug Event
| Article | Year |
|---|---|
Treatment Outcomes and Adverse Drug Effects of Ethambutol, Cycloserine, and Terizidone for the Treatment of Multidrug-Resistant Tuberculosis in South Africa.
Topics: Adult; Antitubercular Agents; Cycloserine; Drug-Related Side Effects and Adverse Reactions; Ethambutol; Humans; Isoxazoles; Oxazolidinones; Pharmaceutical Preparations; South Africa; Treatment Outcome; Tuberculosis, Multidrug-Resistant | 2020 |
Novel Adverse Events of Iloperidone: A Disproportionality Analysis in US Food and Drug Administration Adverse Event Reporting System (FAERS) Database.
Topics: Adverse Drug Reaction Reporting Systems; Akathisia, Drug-Induced; Antipsychotic Agents; Databases, Factual; Drug-Related Side Effects and Adverse Reactions; Humans; Isoxazoles; Piperidines; United States; United States Food and Drug Administration | 2019 |
Leflunomide: an unlikely trigger and mechanistically a beneficial drug for alopecia areata.
Topics: Alopecia Areata; Drug-Related Side Effects and Adverse Reactions; Humans; Isoxazoles; Leflunomide | 2019 |
Assessment of afoxolaner efficacy against Otodectes cynotis infestations of dogs.
Topics: Administration, Oral; Animals; Dog Diseases; Dogs; Drug-Related Side Effects and Adverse Reactions; Insecticides; Isoxazoles; Mite Infestations; Naphthalenes; Otoscopy; Psoroptidae; Treatment Outcome | 2016 |
Predicting possible zonisamide hypersensitivity syndrome.
Topics: Adult; Age Factors; Aged; Animals; Anticonvulsants; Cell Survival; Diagnostic Techniques and Procedures; Drug Eruptions; Drug-Related Side Effects and Adverse Reactions; Exanthema; Female; Humans; Isoxazoles; Lymphocytes; Male; Mice; Microsomes, Liver; Middle Aged; Sensitivity and Specificity; Sex Factors; Sulfamethoxazole; Young Adult; Zonisamide | 2008 |
Disposition and safety of zonisamide after intravenous and oral single dose and oral multiple dosing in normal hound dogs.
Topics: Administration, Oral; Animals; Anticonvulsants; Area Under Curve; Biological Availability; Dogs; Drug-Related Side Effects and Adverse Reactions; Female; Half-Life; Injections, Intravenous; Isoxazoles; Linear Models; Male; Metabolic Clearance Rate; Protein Binding; Thyroid Hormones; Zonisamide | 2008 |
Causes of DMARD withdrawal following ADR within 6 months of initiation among Indian rheumatoid arthritis patients.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Hydroxychloroquine; India; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Retrospective Studies; Sulfasalazine; Time Factors | 2012 |
Postmarketing surveillance for drug safety.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Drug-Related Side Effects and Adverse Reactions; Humans; Isoxazoles; Leflunomide; Peripheral Nervous System Diseases; Product Surveillance, Postmarketing; Safety; United States; United States Food and Drug Administration | 2004 |
Lessons to learn from the COX-2 saga. Yes, FDA reforms are needed. And marketing distorts how medications are used. But one moral to the story is that all drugs have risks.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cardiovascular Diseases; Celecoxib; Cyclooxygenase 2 Inhibitors; Drug-Related Side Effects and Adverse Reactions; Humans; Isoxazoles; Lactones; Marketing of Health Services; Naproxen; Pyrazoles; Risk Assessment; Sulfonamides; Sulfones; United States; United States Food and Drug Administration | 2005 |
A new-drug roundup.
Topics: Acetates; Anti-Asthmatic Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Antitubercular Agents; Antiviral Agents; Capecitabine; Cyclopropanes; Deoxycytidine; Drug Therapy; Drug-Related Side Effects and Adverse Reactions; Etanercept; Fluorouracil; Humans; Immunoglobulin G; Isoxazoles; Leflunomide; Phosphodiesterase Inhibitors; Piperazines; Purines; Quinolines; Receptors, Tumor Necrosis Factor; Rifampin; Sildenafil Citrate; Sulfides; Sulfones; Thionucleotides | 1999 |